Comparison of Extracorporeal Shock Wave Therapy and Low-Level Laser Therapy in Patients With Lateral Epicondylitis
Effects of Extracorporeal Shock Wave Therapy Versus Low-Level Laser Therapy on Ultrasonographic Tendon Thickness and Clinical Outcomes in Patients With Lateral Epicondylitis
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Background: Lateral epicondylitis is a common musculoskeletal condition characterized by pain and functional impairment of the elbow, often associated with degenerative changes in the common extensor tendon. Extracorporeal shock wave therapy (ESWT) and low-level laser therapy (LLLT) are widely used noninvasive treatment modalities; however, comparative evidence regarding their clinical and structural effects remains limited. Objective: This study aims to compare the effects of ESWT and LLLT on pain intensity, elbow function, quality of life, grip strength, and ultrasonographic characteristics of the extensor tendon (thickness and echogenicity) in patients with lateral epicondylitis. Methods: This prospective, randomized, single-blind, comparative clinical trial will be conducted at the Physical Medicine and Rehabilitation outpatient clinic. Patients aged 18-65 years with clinically diagnosed lateral epicondylitis and symptom duration of at least six weeks will be included. All participants will receive a tennis elbow brace and a standardized exercise program. Participants will be randomly assigned to receive either ESWT or LLLT. ESWT will be applied to the lateral epicondyle region using a standardized protocol once weekly for 3 weeks. LLLT will be administered to the same region using standard clinical protocol three times per week for 3 weeks. Assessments will be performed before and after treatment. Pain will be evaluated using the Visual Analog Scale (VAS), elbow function using the Patient-Rated Tennis Elbow Evaluation (PRTEE), quality of life using the Short Form-36 (SF-36), and grip strength using a hand dynamometer. Ultrasonographic evaluation of the common extensor tendon will be performed by a blinded specialist using a high-frequency linear probe to assess tendon thickness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2026
CompletedStudy Start
First participant enrolled
April 29, 2026
CompletedFirst Posted
Study publicly available on registry
May 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 29, 2026
May 4, 2026
April 1, 2026
5 months
April 27, 2026
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity will be measured by the Visual Analog Scale (VAS)
Pain intensity will be measured by the VAS, a 10-cm horizontal scale ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to indicate their pain level, and the score will be recorded accordingly.
Baseline and after 3 weeks of treatment
Secondary Outcomes (4)
Elbow function and pain-related disability will be assessed using the Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire.
Baseline and after 3 weeks of treatment
Quality of life will be assessed using the Short Form-36 (SF-36) questionnaire
Baseline and after 3 weeks of treatment
Grip strength will be measured using a Jamar hand dynamometer
Baseline and after 3 weeks of treatment
Ultrasonographic assessment of extensor tendon thickness
Baseline and after 3 weeks of treatment
Study Arms (2)
ESWT Group
EXPERIMENTALParticipants in the experimental group will receive a tennis elbow brace and a standardized exercise program, and additionally undergo extracorporeal shock wave therapy (ESWT). ESWT will be applied to the lateral epicondyle region over the common extensor tendon using a standardized protocol (1.6 bar, 2000 pulses, 10 Hz, once weekly for 3 weeks).
LLLT Group
ACTIVE COMPARATORParticipants in the active comparator group will receive a tennis elbow brace and a standardized exercise program, and additionally undergo low-level laser therapy (LLLT). LLLT will be applied to the lateral epicondyle region over the common extensor tendon using a standardized protocol three times per week for 3 weeks at four points, 40 seconds per point, with a dose of 4 J/cm².
Interventions
ESWT will be applied to the lateral epicondyle region using a standardized protocol for 3 sessions in three weeks
LLLT will be applied to the lateral epicondyle region using a standardized protocol three times per week for 3 weeks
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of lateral epicondylitis based on physical examination findings
- Symptom duration of at least 6 weeks
- Presence of lateral elbow pain aggravated by wrist extension and/or gripping activities
- Ability to understand and comply with study procedures
- Provision of written informed consent
You may not qualify if:
- Previous surgery involving the affected elbow
- History of corticosteroid or other injection therapy to the affected elbow within the last 6 months
- Presence of inflammatory rheumatic diseases (e.g., rheumatoid arthritis)
- Neurological disorders affecting the upper extremity
- Systemic inflammatory or metabolic diseases that may affect tendon structure or healing
- Cervical radiculopathy or other causes of referred upper extremity pain
- Pregnancy or breastfeeding
- Use of anticoagulant therapy or bleeding disorders
- Severe comorbid conditions that may interfere with participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hitit Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pınar Başaran, Dr
Hitit University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single (Outcome assessor)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
April 27, 2026
First Posted
May 4, 2026
Study Start
April 29, 2026
Primary Completion (Estimated)
September 29, 2026
Study Completion (Estimated)
September 29, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to institutional regulations and the absence of participant consent for public data sharing.